Table 2.
Data obtained at baseline in all patients and used in the minimization step in randomizing patients to the two trial arms.
| Characteristic |
Group 1 (N = 47) |
Group 2 (N = 46) |
|---|---|---|
| Control | Metastasectomy | |
| Gender | ||
| Male | 28 | 31 |
| Female | 19 | 15 |
| Age (years) | ||
| 61+ | 33 | 32 |
| 60 or under | 14 | 14 |
| Lung metastases | ||
| 1 | 16 | 18 |
| 2–4 | 26 | 24 |
| 5+ | 5 | 4 |
| CEA (ng/ml) | ||
| <5 | 36 | 37 |
| 5–10 | 6 | 6 |
| 10+ | 5 | 3 |
| Prior liver resection | ||
| Yes | 13 | 14 |
| No | 34 | 32 |
| Years since 1o CRC resection | ||
| <1 | 7 | 7 |
| 1–3 | 28 | 26 |
| 3+ | 12 | 13 |
| CRC Stage | ||
| T stage | ||
| 1 | 2 | 2 |
| 2 | 8 | 7 |
| 3+ | 37 | 37 |
| N Stage | ||
| 0 | 25 | 24 |
| 1+ | 22 | 22 |
Values represent the number of patients.
CEA, carcinoembryonic antigen; CRC, colorectal cancer.